Bill Moffitt, Chairman
Bill Moffitt is a US-based industry veteran with an accomplished track record of building early stage medtech companies that have helped shape the healthcare industry.
As CEO of i-STAT and Nanosphere he developed successful strategic alliances, launched two IPOs, and has also had numerous successful exits of companies where he was CEO or chairman.
From innovative, high-tech start-ups to larger more mature companies, Bill possesses demonstrated ability to attract and maintain investor support at all stages of a company’s development.
Dr Everard Mascarenhas, CEO
Everard is an experienced commercial manager with more than 25 years’ experience of commercialising early stage technology. He has built two start-ups from concept through to revenues and secured several £m of investment for these companies. He is responsible for the commercial operations of the company. Prior to joining Sarissa, Everard was an Investment Executive with Mercia Fund Management. He is also an NXD on three other early stage technology companies.
Professor Nick Dale, Founder and CTO
Nick is the founder of Sarissa Biomedical and Ted Pridgeon Professor of Neuroscience at the University of Warwick. His expertise is in the fields of neuroscience and biosensors and has received over £9m of grant funding from UK research councils, medical charities and the EU. He is the co-inventor on five patents and has published more than 100 peer-reviewed papers in international scientific journals. Nick directs the technical work of the company and is the Principal Investigator on the clinical trials.
Professor Bruno Frenguelli, Non-Executive Director
Founder’s Director and leading neuroscientist, Bruno has research interests in stroke, epilepsy and traumatic brain injury. Bruno, together with Nick, made the first direct measurements of purine release in in vitro models of stroke.
George Zajicek, Non-Executive Director
George is a seasoned healthcare professional who has worked in the pharmaceutical, in vitro diagnostics (IVD) and medical device industries. He is a registered pharmacist and is currently working as a consultant to several IVD companies in addition to being Executive Chairman of Probe Scientific. He has served on several company Boards and has expertise in regulatory affairs, clinical trials, marketing, development and reimbursement systems, in addition to general management and acquisitions.